Uses supported by clinical data
Treatment of lower urinary tract symptoms (nocturia, polyuria, urinary retention) secondary to BPH stages I and II, as defined by Alken, in cases where diagnosis of prostate cancer is negative.
Owing to its effects on androgen and estrogen metabolism, the use of Fructus Serenoae Repentis during pregnancy or lactation and in children under the age of 12 years is contraindicated.
Fructus Serenoae Repentis relieves the symptoms associated with BPH, but does not have an effect on the size of the prostate. If symptoms worsen or do not improve, or in cases of blood in the urine or acute urinary retention, contact a physician.